103 related articles for article (PubMed ID: 9689595)
1. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
Vejlstrup NG; Bouloumie A; Boesgaard S; Andersen CB; Nielsen-Kudsk JE; Mortensen SA; Kent JD; Harrison DG; Busse R; Aldershvile J
J Mol Cell Cardiol; 1998 Jun; 30(6):1215-23. PubMed ID: 9689595
[TBL] [Abstract][Full Text] [Related]
2. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.
Wang Y; Guo Y; Zhang SX; Wu WJ; Wang J; Bao W; Bolli R
J Mol Cell Cardiol; 2002 Jan; 34(1):5-15. PubMed ID: 11812160
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase in human heart failure.
Haywood GA; Tsao PS; von der Leyen HE; Mann MJ; Keeling PJ; Trindade PT; Lewis NP; Byrne CD; Rickenbacher PR; Bishopric NH; Cooke JP; McKenna WJ; Fowler MB
Circulation; 1996 Mar; 93(6):1087-94. PubMed ID: 8653828
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase gene transcription and protein activity in the rat heart during endotoxaemia.
Robinson NM; Westmore KR; Martin JF; Emson P; Charles IG
Biochem Biophys Res Commun; 1997 Feb; 231(1):211-6. PubMed ID: 9070251
[TBL] [Abstract][Full Text] [Related]
6. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
[TBL] [Abstract][Full Text] [Related]
7. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats.
Heba G; Krzemiński T; Porc M; Grzyb J; Dembińska-Kieć A
J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
[TBL] [Abstract][Full Text] [Related]
9. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.
Patten RD; Denofrio D; El-Zaru M; Kakkar R; Saunders J; Celestin F; Warner K; Rastegar H; Khabbaz KR; Udelson JE; Konstam MA; Karas RH
J Am Coll Cardiol; 2005 May; 45(9):1419-24. PubMed ID: 15862412
[TBL] [Abstract][Full Text] [Related]
10. Suppressed expression of GTP cyclohydrolase I mRNA and accelerated expression of inducible nitric oxide synthase mRNA in endomyocardial biopsy specimens from patients with dilated cardiomyopathy.
Ohtsuki M; Nomura T; Morimoto S; Hiramitsu S; Uemura A; Kato S; Kato Y; Shiraishi H; Shimokubo J; Yamamoto N; Hishida H
Clin Chim Acta; 2005 Mar; 353(1-2):103-7. PubMed ID: 15698596
[TBL] [Abstract][Full Text] [Related]
11. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
Di Napoli P; Maggi A; Spina R; Barsotti L; Taccardi AA; Stuppia L; Vianale G; Palka G; Barsotti A
Cardiologia; 1999 Jan; 44(1):69-74. PubMed ID: 10188333
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy.
Francis SE; Holden H; Holt CM; Duff GW
J Mol Cell Cardiol; 1998 Feb; 30(2):215-23. PubMed ID: 9514998
[TBL] [Abstract][Full Text] [Related]
13. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
Szotowski B; Goldin-Lang P; Antoniak S; Bogdanov VY; Pathirana D; Pauschinger M; Dörner A; Kuehl U; Coupland S; Nemerson Y; Hummel M; Poller W; Hetzer R; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2005 Apr; 45(7):1081-9. PubMed ID: 15808768
[TBL] [Abstract][Full Text] [Related]
14. ACE2 gene expression is up-regulated in the human failing heart.
Goulter AB; Goddard MJ; Allen JC; Clark KL
BMC Med; 2004 May; 2():19. PubMed ID: 15151696
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
[TBL] [Abstract][Full Text] [Related]
16. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia.
Gupta A; Sharma AC
Shock; 2003 Oct; 20(4):375-81. PubMed ID: 14501953
[TBL] [Abstract][Full Text] [Related]
17. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
18. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.
de Belder AJ; Radomski MW; Why HJ; Richardson PJ; Martin JF
Br Heart J; 1995 Oct; 74(4):426-30. PubMed ID: 7488459
[TBL] [Abstract][Full Text] [Related]
19. Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course.
Koch A; Burgschweiger A; Herpel E; Sack FU; Schirmacher P; Szabo GB; Karck M; Schnabel PA
Eur J Cardiothorac Surg; 2007 Oct; 32(4):639-43. PubMed ID: 17689088
[TBL] [Abstract][Full Text] [Related]
20. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
